E-LIB Suche - Ergebnisse für: Rowland-Yeo, Karen

1

The use of quantitative clinical pharmacology approaches to..:

Wood, Nolan D. ; Smith, Danelle ; Kinrade, Sally A....
PLOS Neglected Tropical Diseases. 18 (2024) 8 - p. e0012351 , 2024

Link: https://doi.org/10.1371/..

2

Application of PBPK modeling to evaluate pharmacokinetic dr..:

Abla, Nada ; Almond, Lisa ; Dickins, Maurice...
Drug Metabolism and Pharmacokinetics. 34 (2019) 1 - p. S68-S69 , 2019

Link: https://doi.org/10.1016/..

3

Modelling methods and case studies:

Rowland-Yeo, Karen
Drug Metabolism and Pharmacokinetics. 32 (2017) 1 - p. S4 , 2017

Link: https://doi.org/10.1016/..

4

Emerging areas of research in the assessment of pharmacokin..:

Tortorici, Michael A. ; Cutler, David L. ; Hazra, Anasuya...
The Journal of Clinical Pharmacology. 55 (2015) 3 - p. 241-250 , 2015

Link: https://doi.org/10.1002/..

5

Response to "Ethnic-Specific In Vitro–In Vivo Extrapolation..:

Barter, Zoe E. ; Tucker, Geoffrey T. ; Rowland-Yeo, Karen
Clinical Pharmacokinetics. 53 (2013) 2 - p. 203-203 , 2013

Link: https://doi.org/10.1007/..

6

Differences in Cytochrome P450-Mediated Pharmacokinetics Be..:

Barter, Zoe E. ; Tucker, Geoffrey T. ; Rowland-Yeo, Karen
Clinical Pharmacokinetics. 52 (2013) 12 - p. 1085-1100 , 2013

Link: https://doi.org/10.1007/..

7

Evaluation of the novel in vitro systems for hepatic drug c..:

Houston, J. Brian ; Rowland-Yeo, Karen ; Zanelli, Ugo
Toxicology in Vitro. 26 (2012) 8 - p. 1265-1271 , 2012

Link: https://doi.org/10.1016/..

8

Application of a Systems Approach to the Bottom-Up Assessme..:

Ghobadi, Cyrus ; Johnson, Trevor N. ; Aarabi, Mohsen...
Clinical Pharmacokinetics. 50 (2011) 12 - p. 809-822 , 2011

Link: https://doi.org/10.2165/..

9

A Semi-Mechanistic Model to Predict the Effects of Liver Ci..:

Johnson, Trevor N. ; Boussery, Koen ; Rowland-Yeo, Karen..
Clinical Pharmacokinetics. 49 (2010) 3 - p. 189-206 , 2010

Link: https://doi.org/10.2165/..

10

The impact of experimental design on assessing mechanism-ba..:

Van, Linh M. ; Heydari, Amir ; Yang, Jiansong...
Journal of Psychopharmacology. 20 (2006) 6 - p. 834-841 , 2006

Link: https://doi.org/10.1177/..

11

Coronary and Cardiovascular Risk Estimation for Primary Pre..:

Wallis, Erica J. ; Ramsay, Lawrence E. ; Haq, Iftikhar Ul...
BMJ: British Medical Journal. 320 (2000) 7236 - p. 671-676 , 2000

Link: https://www.jstor.org/st..

12

Protein binding of aspirin and salicylate measured by in vi..:

Ghahramani, Parviz ; Rowland-Yeo, Karen ; Yeo, Wilfred W...
Clinical Pharmacology & Therapeutics. 63 (1998) 3 - p. 285-295 , 1998

Link: https://doi.org/10.1016/..

13

Dose Optimization Informed by PBPK Modeling: State‐of‐the A..:

Rowland Yeo, Karen ; Gil Berglund, Eva ; Chen, Yuan
Clinical Pharmacology & Therapeutics. , 2024

Link: https://doi.org/10.1002/..

14

Physiologically Based Pharmacokinetic Modeling to Determine..:

Pan, Xian ; Rowland Yeo, Karen
Clinical Pharmacology & Therapeutics. 114 (2023) 1 - p. 182-191 , 2023

Link: https://doi.org/10.1002/..

15

Physiologically Based Pharmacokinetic Modelling to Predict ..:

Rowland Yeo, Karen ; Hatley, Oliver ; Small, Ben G..
Pharmaceutics. 15 (2023) 7 - p. 1922 , 2023

Link: https://doi.org/10.3390/..